ATE74517T1 - Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. - Google Patents

Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Info

Publication number
ATE74517T1
ATE74517T1 AT88300407T AT88300407T ATE74517T1 AT E74517 T1 ATE74517 T1 AT E74517T1 AT 88300407 T AT88300407 T AT 88300407T AT 88300407 T AT88300407 T AT 88300407T AT E74517 T1 ATE74517 T1 AT E74517T1
Authority
AT
Austria
Prior art keywords
interferon
alpha
treatment
gamma
leukemias
Prior art date
Application number
AT88300407T
Other languages
English (en)
Inventor
Paul Philip Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21712239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE74517(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE74517T1 publication Critical patent/ATE74517T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88300407T 1987-01-20 1988-01-19 Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. ATE74517T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US473187A 1987-01-20 1987-01-20
EP88300407A EP0276120B1 (de) 1987-01-20 1988-01-19 Behandlung von einigen Leukämien mit einer Zusammensetzung von Interferon-gamma und Interferon-alpha

Publications (1)

Publication Number Publication Date
ATE74517T1 true ATE74517T1 (de) 1992-04-15

Family

ID=21712239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88300407T ATE74517T1 (de) 1987-01-20 1988-01-19 Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Country Status (7)

Country Link
EP (1) EP0276120B1 (de)
JP (1) JPS63198636A (de)
AT (1) ATE74517T1 (de)
CA (1) CA1321348C (de)
DE (1) DE3869789D1 (de)
ES (1) ES2039276T3 (de)
GR (1) GR3004928T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤
HRP20130098T1 (hr) 2003-10-14 2013-02-28 F. Hoffmann - La Roche Ag MAKROCIKLIÄŚKE KARBOKSILNE KISELINE I ACILSULFONAMIDNI SPOJEVI KAO INHIBITORI REPLIKACIJE HCV-a
KR101294467B1 (ko) 2005-07-25 2013-09-09 인터뮨, 인크. Ｃ형 간염 바이러스 복제의 신규 거대고리형 억제제
BRPI0617274A2 (pt) 2005-10-11 2011-07-19 Intermune Inc compostos e métodos para a inibição de replicação viral de hepatite c
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
JPS61263929A (ja) * 1986-04-30 1986-11-21 Hayashibara Takeshi 抗タイプ２インターフェロン感受性疾患剤
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia

Also Published As

Publication number Publication date
CA1321348C (en) 1993-08-17
EP0276120B1 (de) 1992-04-08
ES2039276T3 (es) 1993-09-16
JPS63198636A (ja) 1988-08-17
EP0276120A2 (de) 1988-07-27
GR3004928T3 (de) 1993-04-28
DE3869789D1 (de) 1992-05-14
EP0276120A3 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
DK163279C (da) Multimineralkosttilskudstablet med kontrolleret afgivelse
DE3579453D1 (de) Monolithische integration von lichtemittierenden elementen und steuerelektronik.
NO875355L (no) Rensing av rekombinant beta-interferon innbefattende rp-hplc.
DE3381553D1 (de) Synergistische humaninterferonaktivitaet.
KR890701135A (ko) 감마 인터페론 제제
DK201590D0 (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
ATE74517T1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DE3777224D1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
NZ221406A (en) Antitumour composition containing an interleukin-2 active substance and an interferon-alpha
DK103891D0 (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DE69104619D1 (de) Verwendungsmethoden von humanem Gammainterferon 4-134.
NO891715L (no) Ekspresjon av interferon-gamma i metylotrofe gjaersorter.
DK527287D0 (da) Polypeptid med interleukin-2-aktiviteter
ATA292286A (de) Schultisch mit neigbarer tischplatte
ATE73346T1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
PT81147B (de) Bekaempfung von durchfaellen mit alpha-interferonen
ES1000854Y (es) Mesa de billar perfeccionada
BR6600321U (pt) Estruturas metalicas de cadeira e mesa
DK0381584T3 (da) Anvendelse af visse gamma-interferoner til behandling af ovariecancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked